The risk of sinusoidal obstruction syndrome (SOS) in allogeneic hematopoietic stem cell transplantation after prior Gemtuzumab Ozogamicin treatment: a retrospective study on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Authors
Battipaglia, GLabopin, M
Candoni, A
Fanin, R
El, C
Blaise, D
Michallet, M
Ruggeri, A
Contentin, N
Ribera, J
Stadler, M
Sierra, J
Borne, P
Bloor, Adrian
Socie, G
Mohty, M
Nagler, A
Affiliation
Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine, ParisIssue Date
2015